Previous research using the same dataset has shown wild‐type TP53 and basal‐like breast tumors to be associated with cytotoxic T‐cell signatures, and that basal‐like tumors had a high frequency of p.R175H mutations (Lu et al., 2013). The gene discussed is TP53; the disease is breast neoplasm.